Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Outcomes for patients with multiple myeloma (MM) have improved in recent years owing to use of novel agents and high-dose therapy followed by autologous stem cell transplant (ASCT). We analyzed the outcomes of 511 consecutive patients treated with novel therapies at our institution between 2006 and...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia
Main Authors: Majithia, N, Rajkumar, SV, Lacy, MQ, Buadi, FK, Dispenzieri, A, Gertz, MA, Hayman, SR, Dingli, D, Kapoor, P, Hwa, L, Lust, JA, Russell, SJ, Go, RS, Kyle, RA, Kumar, SK
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541860/
https://ncbi.nlm.nih.gov/pubmed/27211270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.147
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items